InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Quinlan Amy. Director active across 1 company, notably Vor Biopharma Inc.. Cumulatively, 3 filings have been published. Activity tracked since 1 August 2024. The latest transaction was disclosed on 6 November 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条